Artificial intelligence in autoimmune pancreatitis: Differentiating immunoglobulin G4-related pancreatitis from pancreatic ductal adenocarcinoma
Artificial Intelligence in Gastroenterology · 08.11.2026 · 7 (3)
DOI: 10.35712/aig.123890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Intelligence in Gastroenterology, online erschienen am 08.11.2026. Verfasst von Ahmed Salman und 2 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Autoimmune pancreatitis (AIP), specifically the immunoglobulin G4-related type-1 variant, serves as a significant benign mimic of pancreatic ductal adenocarcinoma (PDAC). Focal or mass-forming AIP can manifest as obstructive jaundice, a pancreatic mass, ductal narrowing, weight loss, and elevated tumor markers that may resemble those of PDAC. Misdiagnosis can result in either unnecessary pancreatic surgery or delayed treatment for cancer. Artificial intelligence (AI), including radiomics, machine learning, deep learning, and multimodal decision-support systems, offers a possible solution for this diagnostic dilemma. AI-based imaging is able to extract quantitative characteristics from a variety of modalities, such as computed tomography, magnetic resonance imaging, diffusion-weighted imaging, positron emission tomography, and endoscopic ultrasonography that may not be apparent by visual inspection. Digital pathology and models combining radiological, serological, histological and clinical variables are also on the rise. Current data is limited by small retrospective single-center cohorts, uneven imaging techniques, dependency on segmentation, and the absence of adequate external validation. AI should be seen as a supplement, not a substitute, to the professional multidisciplinary assessment, boosting the risk classification, directing the tissue collection, and steroid trials, and avoiding unnecessary procedures without delaying PDAC diagnosis. Future research should target prospective multicenter validation, uniform datasets, improved explainability and therapeutically significant objectives.
Zitieren
APA
Salman, A., Elewa, A., & Marwan, A. (2026). Artificial intelligence in autoimmune pancreatitis: Differentiating immunoglobulin G4-related pancreatitis from pancreatic ductal adenocarcinoma. Artificial Intelligence in Gastroenterology, 7(3). https://doi.org/10.35712/aig.123890
Vancouver
Salman A, Elewa A, Marwan A. Artificial intelligence in autoimmune pancreatitis: Differentiating immunoglobulin G4-related pancreatitis from pancreatic ductal adenocarcinoma. Artificial Intelligence in Gastroenterology. 2026;7(3). doi:10.35712/aig.123890
BibTeX
@article{Salman2026,
author = {Salman, Ahmed and Elewa, Ahmed and Marwan, Ahmad},
title = {Artificial intelligence in autoimmune pancreatitis: Differentiating immunoglobulin G4-related pancreatitis from pancreatic ductal adenocarcinoma},
journal = {Artificial Intelligence in Gastroenterology},
year = {2026},
volume = {7},
number = {3},
doi = {10.35712/aig.123890}
}
EUVIMED